Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYDG.L Regulatory News (HYDG)

  • There is currently no data for HYDG

Half Year Update

2 Jul 2012 07:00

RNS Number : 5678G
Hydrogen Group PLC
02 July 2012
 



 

 

2 July 2012

Hydrogen Group plc

Half Year Update

Hydrogen Group plc ('Hydrogen' or the 'Group'), the global specialist recruitment business, is today issuing a trading update in respect of the six months ended 30 June 2012 (the 'period').

The Group continued to trade in line with expectations during the period despite the on-going macroeconomic uncertainty, delivering modest growth in Net Fee Income ('NFI') year on year.

Hydrogen continued to progress its strategy of growing a balanced business by carefully selecting and developing its presence in attractive geographies and markets. Group NFI generated from outside the UK increased to approximately 40% during the first six months and, as at the period end, more than 50% of client facing employees were servicing growth markets overseas. The Group renamed its Pharmaceuticals practice to Life Sciences, more accurately reflecting the increased scope of its activity, and together with Oil & Gas resulted in approximately 37% of Group NFI being generated from Technical & Scientific markets. The continued strong performance of these relatively new practices demonstrates Hydrogen's ability to identify new markets as well as its flexibility to deliver quickly on the significant growth opportunities they offer.

Ensuring Hydrogen has the correct infrastructure in place to facilitate long-term growth is a key strategic focus and the Group has continued to make good progress in this area during the period. The Group piloted its new cloud-based global customer relationship management system ("CRM") during the first six months and this will be rolled out across the rest of the business in the second half of the year. The Group also launched the rebrand of its individual UK brands under the Hydrogen brand. Together with the new CRM system this will deliver long-term competitive advantage by enabling Hydrogen to provide a more consistent global service to clients and candidates.

Commenting, Ian Temple, Executive Chairman said:

"Hydrogen has performed well in the first half of the year despite continued uncertainty in the global recruitment markets. We have continued to focus on our strategy of building global practices in our specialist markets and we remain well positioned for the long term.

The business continues to trade in line with our expectations. Nevertheless, on-going debt issues in Europe and the uncertain economic outlook mean that visibility across recruitment markets remains limited. The impact of the Olympic Games on UK recruitment markets in the second half of the year is unknown. However, we are confident in the performance of our international operations and contractor activity, and that the Group remains on target to achieve its 2012 goals."

Enquiries:

Hydrogen Group plc

020 7240 2500

Ian Temple, Executive Chairman

Tim Smeaton, Chief Executive

 

Hudson Sandler

020 7796 4133

Alex Brennan

 

Oriel Securities (NOMAD)

 

020 7710 7600

Nicholas How

Emma Griffin

 

Notes to Editors:

Hydrogen is a specialist recruitment business with a turnover in excess of £150m. We build relationships by finding specialist candidates our clients have difficulty sourcing, placing professionals in more than 50 countries.

Our joined-up practice teams combine international reach with local expertise and specialist knowledge, to provide visibility of world class candidates.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFIRRSIAFIF
Date   Source Headline
19th May 20205:26 pmRNSNotice of AGM
7th Apr 20207:00 amRNSFinal results for year ended 31 December 2019
27th Feb 20202:05 pmRNSSecond Price Monitoring Extn
27th Feb 20202:00 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSTrading Update
15th Nov 201912:19 pmRNSTrading Statement
18th Sep 20195:29 pmRNSDealing in Company shares
9th Sep 20196:01 pmRNSDealing in Company shares
4th Sep 20195:30 pmRNSDealing in Company shares
4th Sep 20195:26 pmRNSHolding(s) in Company
3rd Sep 20197:43 amRNSInterim Results
29th Aug 20197:00 amRNSInterim Results Date
15th Jul 20197:00 amRNSTrading Statement and Notice of Results
24th May 20198:43 amRNSResult of AGM
23rd May 20197:00 amRNSAGM Statement
22nd May 20193:49 pmRNSIssue of Equity
29th Apr 20197:00 amRNSNotice of AGM
25th Apr 20192:32 pmRNSIssue of Equity
12th Apr 20194:32 pmRNSHolding(s) in Company
2nd Apr 20197:00 amRNSFinal Results
12th Mar 20197:00 amRNSMaterial Contract Renewal with FTSE100 Retail Bank
25th Jan 20197:00 amRNSTrading Statement
17th Dec 20186:08 pmRNSDealing in Company shares
26th Nov 20187:00 amRNSDealing in Company shares
6th Nov 20187:00 amRNSTrading Statement
1st Nov 20187:00 amRNSIssue of Equity
31st Oct 20187:00 amRNSDealing in Company shares
30th Oct 20187:00 amRNSDealing in Company shares
17th Oct 20184:00 pmRNSDigital Marketing Recognition
10th Oct 20187:00 amRNSUS Office Expansion
19th Sep 20184:21 pmRNSInterim Dividend Timetable
18th Sep 20187:00 amRNSHalf-year Report
15th Aug 201812:52 pmRNSHolding(s) in Company
10th Aug 20181:57 pmRNSReplacement: Issue of Equity
7th Aug 20182:46 pmRNSIssue of Equity
17th Jul 20187:00 amRNSTrading Update and Notice of Interim Results
3rd Jul 20187:00 amRNSNotice of trading update
29th Jun 20183:15 pmRNSIssue of Equity and Director Dealing
1st Jun 20183:38 pmRNSTotal Voting Rights
1st Jun 20182:03 pmRNSHolding(s) in Company
31st May 20184:48 pmRNSDirector/PDMR Shareholding
31st May 201812:10 pmRNSIssue of Equity, Director / PDMR holding
25th May 201812:09 pmRNSResult of AGM
25th May 20187:00 amRNSAGM Statement
16th Apr 20183:32 pmRNSHolding(s) in Company
10th Apr 20187:00 amRNSFinal Results
3rd Apr 20187:00 amRNSTotal Voting Rights
26th Mar 20187:00 amRNSNotice of Results
11th Jan 20187:00 amRNSBlock listing Interim Review - Unapproved
11th Jan 20187:00 amRNSBlock listing Interim Review - EMI

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.